SEARCH BY
Galecto is a clinical-stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets that are at the heart of fibrosis, inflammation, and cancer. Galecto was formed in 2011 and is based in Copenhagen, Denmark.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Life Science M&A | 2 of 2 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 2 of 2 |
| Year: 2025 M&A | 1 of 1 |
| Size (of disclosed) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2020-01-07 |
PharmAkea
San Diego, California, United States PharmAkea is a biopharmaceutical company and is a developer of high-quality, small molecule drug candidates against protein targets involved in fibroproliferative diseases. PharmAkea was founded in 2012 and is based in San Diego, California. |
Buy | - |